Half Year Trading Update

Victrex PLC
04 April 2008



4 April 2008

                                  Victrex plc

                            Half Year Trading Update


The Company announces its trading update for the six months ended 31 March 2008.

Trading in the first half has continued in line with expectations. We have
achieved further sales growth, with record first half sales volume of
approximately 1,293 tonnes, some 6% ahead of the second half of last year (1,222
tonnes) and in line with the previous first half of 1,286 tonnes.

   •United States volume showed continued growth at 418 tonnes which was 4%
    ahead of last year's second half of 402 tonnes and 7% ahead of the previous
    first half of 389 tonnes.

   •European sales volume saw a return to growth at 646 tonnes, which was 10%
    up on the second half of last year (587 tonnes) and close to the previous
    first half (656 tonnes).

   •Asia-Pacific sales volume was maintained at 229 tonnes, in line with the
    second half of last year (233 tonnes) and 5% below the previous first half
    (241 tonnes).

   •At approximately £11.7m, revenues of Invibio(R), the medical implant
    materials business, continued to show good growth, up by 19% on last year's
    second half of £9.8m and by 23% on the previous first half of £9.5m.

The announcement of the Company's results for the six months ended 31 March 2008
will be made on Tuesday, 20 May 2008.


                                     -Ends-


For further information please contact:

Victrex plc                                              01253 897700
Michael Peacock, Finance Director
Hogarth Partnership Limited                              0207 357 9477
Nick Denton / Barnaby Fry


Victrex plc is an innovative, world leader in high performance materials through
the manufacture of VICTREX(R) PEEK(TM) polymer, a high performance, easy to 
process thermoplastic.

VICTREX PEEK has a unique combination of chemical, wear, electrical, hydrolysis
and temperature resistance, as well as excellent dimensional, mechanical and
chemical stability combined with inherent purity and low flammability.

End users specify VICTREX PEEK to reduce systems costs, improve part
performance, exploit greater design freedom and create a differentiated
application. VICTREX PEEK is used across a broad range of applications in
diverse markets including transport, industrial, electronics and medical.
Invibio(R), Victrex's biomaterial business, provides specialised solutions for
medical device manufacturers.

The Group's headquarters are in the UK where its manufacturing facilities are
based. This is complemented by a global network of sales, distribution and
technical centres that serve more than 30 countries worldwide.




                      This information is provided by RNS
            The company news service from the London Stock Exchange